KDM6B and colonic neoplasm: Studies have demonstrated vitamin D metabolite 1α,25-dihydroxyvitamin D (3) [1,25(OH) (2)D (3)] modulates the KDM6B gene promoter and increases the level of KDM6B RNA in human colon cancer cells (47).